查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600111

免疫組織化學市場：按產品類型、疾病類型、最終用戶、應用分類 - 全球預測 2025-2030

Immunohistochemistry Market by Product (Antibodies, Equipment, Kits), Disease Type (Autoimmune Diseases, Cancer, Cardiovascular Diseases), End-user, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年免疫組織化學市場價值為29.8億美元，預計到2024年將達到31.5億美元，複合年成長率為5.88%，到2030年將達到44.6億美元。

免疫組織化學 (IHC) 是一項重要的技術，它結合了解剖學、免疫學和生化技術，利用特異性抗體來識別細胞內的特異性抗原。 IHC 的需求在於其能夠提供對癌症等疾病發病機制的寶貴見解，從而可以客製化治療計劃、提高診斷準確性並改善治療結果。其應用範圍跨越病理學、腫瘤學和藥物開發，在醫院、診斷實驗室和研究機構中發揮重要作用。慢性病的日益普及、技術的進步以及對個人化醫療的需求不斷增加正在推動該市場的成長。然而，高成本、技術複雜、缺乏熟練專業人員等挑戰構成了主要障礙。關鍵的成長要素包括需要準確診斷的癌症患者數量的增加以及生物標記研究的快速增加。數位病理學和自動化平台等技術創新不僅提高了效率和準確性，而且還促進了在單一平台上提供全面分析的多重檢測的發展。為了利用這些機會，公司應該專注於合作研究、投資先進技術並擴大產品系列。然而，克服監管障礙並維持嚴格的品管標準仍然是一個挑戰。專注於開發具有成本效益、高度特異性和穩健的抗體的創新技術，以及人工智慧影像分析和新穎的診斷方法，都是有前景的研究途徑。市場是動態的，重點是技術進步和策略聯盟以擴大應用能力。因此，投資最尖端科技並加強研發的公司能夠充分利用不斷成長的 IHC 市場、解決未滿足的需求並推動未來成長。

主要市場統計
基準年[2023] 29.8億美元
預測年份 [2024] 31.5億美元
預測年份 [2030] 44.6億美元
複合年成長率（%） 5.88%

市場動態：快速發展的免疫組織化學市場的關鍵市場洞察

供需的動態交互作用正在改變免疫組織化學市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 癌症和自體免疫疾病等慢性病人口增加
    • 增加政府補助和舉措以改善癌症診斷
    • 對個人化/客製化醫療的需求不斷成長
  • 市場限制因素
    • 切片檢查樣本的收集、儲存和使用問題
  • 市場機會
    • 免疫組織化學自動化與半自動化系統簡介
    • 診斷公司、研究機構和醫療保健之間的合作
  • 市場挑戰
    • 對產品缺陷和缺乏熟練專業人員的擔憂

波特五力：駕馭免疫組織化學市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解免疫組織化學市場的外部影響

外部宏觀環境因素在塑造免疫組織化學市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解免疫組化市場的競爭格局

對免疫組織化學市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣免疫組化市場供應商的績效評估

FPNV定位矩陣是評估免疫組化市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了免疫組織化學市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，免疫組織化學市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中癌症和自體免疫疾病等慢性疾病的盛行率
      • 擴大政府資助和努力以改善癌症診斷
      • 對個人化/客製化醫療保健的需求不斷成長
    • 抑制因素
      • 切片檢查樣本的收集、儲存和使用問題
    • 機會
      • 自動化和半自動化免疫組織化學系統簡介
      • 診斷公司、研究機構和醫療保健之間的合作
    • 任務
      • 對產品故障和缺乏熟練專業人員的擔憂
  • 市場區隔分析
    • 應用：擴大使用免疫組織化學在法醫學中鑑定犯罪現場的組織樣本和體液
    • 產品：對二抗的需求增加，以獲得準確可靠的結果
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章免疫組織化學市場：依產品

  • 抗體
    • 一抗
    • 二抗
  • 裝置
    • 幻燈片掃描儀
    • 玻片染色系統
    • 組織微陣列
    • 組織處理系統
  • 套件
  • 試劑
    • 封閉血清和試劑
    • 呈色受質
    • 沖淡
    • 固定試劑
    • 組織學染色
    • 有機溶劑
    • 蛋白水解酶
    • 穩定劑

第7章免疫組織化學市場：依疾病類型

  • 自體免疫疾病
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 感染疾病
  • 腎臟疾病

第 8 章免疫組織化學市場：依最終用戶分類

  • 學術研究所
  • CRO
  • 法醫學研究所
  • 醫院和診斷實驗室
  • 製藥和生物製藥公司

第9章免疫組織化學市場：依應用分類

  • 診斷
  • 藥物測試
  • 法醫學

第10章美洲免疫組化市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太免疫組織化市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲免疫組織化學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Tempus 推出先進的 HER2 和 FOLR1 IHC 測試，以增強精準醫療和標靶癌症治療
    • 羅氏 VENTANA HER2 (4B5) 測試獲得 CE 標誌，擴大了 ENHERTU HER2 低轉移性乳癌的治療選擇
    • Cell Signaling Technology 推出 SignalStar Multiplex IHC 技術
    • 丹納赫收購英國Abcam，以加強藥物發現和疾病繪圖能力
  • 戰略分析和建議

公司名單

  • Agilent Technologies Inc.
  • Becton, Dickinson & Company
  • Bio SB
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corporation
  • Biocare Medical LLC
  • Biogenex Laboratories
  • CANDOR Bioscience GmbH
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Diagnostic BioSystems Inc.
  • Eagle Biosciences, Inc.
  • Elabscience Biotechnology Inc.
  • F. Hoffman-La Roche AG
  • Genemed Biotechnologies, Inc. by Sakura Finetek Japan Co., Ltd
  • Histo-Line Laboratories
  • Lunaphore Technologies SA
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • PerkinElmer Inc.
  • Rockland Immunochemicals, Inc.
  • Takara Bio, Inc
  • Thermofisher Scientific, Inc.
Product Code: MRR-A339DAEFADE0

The Immunohistochemistry Market was valued at USD 2.98 billion in 2023, expected to reach USD 3.15 billion in 2024, and is projected to grow at a CAGR of 5.88%, to USD 4.46 billion by 2030.

Immunohistochemistry (IHC) is a critical technique that merges anatomical, immunological, and biochemical methods to identify specific antigens in cells by utilizing specific antibodies, thus offering a profound impact on diagnostic and pharmaceutical fields. The necessity of IHC lies in its capability to provide valuable insights into the pathogenesis of diseases like cancer, enabling the customization of treatment plans, enhancing diagnostic accuracy, and advancing therapeutic outcomes. Its application spans pathology, oncology, and drug development, serving crucial roles in hospitals, diagnostic laboratories, and research institutions. The expanding prevalence of chronic diseases, technological advancements, and an increasing demand for personalized medicine drive growth in this market. However, challenges such as high costs, the complexity of techniques, and limited availability of skilled professionals pose significant barriers. Key growth influences include an increase in cancer cases that necessitate precise diagnostics and the surge in biomarker research. Opportunities arise from technological innovations like digital pathology and automated platforms that boost efficiency and accuracy, as well as the development of multiplex assays that offer comprehensive analysis on a singular platform. To harness these opportunities, companies should focus on collaborative research, investing in advanced technologies, and expanding their product portfolios. However, navigating regulatory hurdles and maintaining rigorous quality control standards remain challenging. Innovations focusing on developing cost-effective, highly specific, and robust antibodies, along with leveraging AI for image analysis and novel diagnostic methods, represent promising research avenues. The market is dynamic, with a substantial emphasis on technological progression and strategic partnerships to broaden application capabilities. Thus, businesses that invest in cutting-edge technologies and robust R&D efforts are well-positioned to capitalize on the growing IHC market, addressing unmet needs and driving future growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.98 billion
Estimated Year [2024] USD 3.15 billion
Forecast Year [2030] USD 4.46 billion
CAGR (%) 5.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunohistochemistry Market

The Immunohistochemistry Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Extensive prevalence of chronic diseases such as cancer and autoimmune diseases among population
    • Increasing government funding and initiatives to improve cancer diagnostics
    • Growing demand for personalized/customized medicine
  • Market Restraints
    • Issues related to the collection, storage, and use of biopsy samples
  • Market Opportunities
    • Introduction of automated and semi-automated immunohistochemistry systems
    • Collaborations between diagnostic companies, research institutes, and healthcare
  • Market Challenges
    • Concerns pertinent to product failure and shortage of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Immunohistochemistry Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunohistochemistry Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunohistochemistry Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunohistochemistry Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunohistochemistry Market

A detailed market share analysis in the Immunohistochemistry Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunohistochemistry Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunohistochemistry Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunohistochemistry Market

A strategic analysis of the Immunohistochemistry Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunohistochemistry Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Becton, Dickinson & Company, Bio SB, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Biocare Medical LLC, Biogenex Laboratories, CANDOR Bioscience GmbH, Cell Signaling Technology, Inc., Danaher Corporation, Diagnostic BioSystems Inc., Eagle Biosciences, Inc., Elabscience Biotechnology Inc., F. Hoffman-La Roche AG, Genemed Biotechnologies, Inc. by Sakura Finetek Japan Co., Ltd, Histo-Line Laboratories, Lunaphore Technologies SA, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, PerkinElmer Inc., Rockland Immunochemicals, Inc., Takara Bio, Inc, and Thermofisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Immunohistochemistry Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antibodies, Equipment, Kits, and Reagents. The Antibodies is further studied across Primary Antibodies and Secondary Antibodies. The Equipment is further studied across Slide Scanners, Slide Staining Systems, Tissue Microarrays, and Tissue Processing Systems. The Reagents is further studied across Blocking Sera & Reagents, Chromogenic Substrates, Diluents, Fixation Reagents, Histological Stains, Organic Solvents, Proteolytic Enzymes, and Stabilizers.
  • Based on Disease Type, market is studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, Diabetes Mellitus, Infectious Diseases, and Nephrological Diseases.
  • Based on End-user, market is studied across Academic & Research Institutes, CROs, Forensic Labs, Hospitals & Diagnostic Laboratories, and Pharma & Biopharma Companies.
  • Based on Application, market is studied across Diagnostics, Drug Testing, and Forensic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Extensive prevalence of chronic diseases such as cancer and autoimmune diseases among population
      • 5.1.1.2. Increasing government funding and initiatives to improve cancer diagnostics
      • 5.1.1.3. Growing demand for personalized/customized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Issues related to the collection, storage, and use of biopsy samples
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of automated and semi-automated immunohistochemistry systems
      • 5.1.3.2. Collaborations between diagnostic companies, research institutes, and healthcare
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns pertinent to product failure and shortage of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Application: Increasing usage of immunohistochemistry in forensic science for the identification of tissue samples and body fluids at crime scenes
    • 5.2.2. Product: Increasing demand for secondary antibodies for accurate and reliable results
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunohistochemistry Market, by Product

  • 6.1. Introduction
  • 6.2. Antibodies
    • 6.2.1. Primary Antibodies
    • 6.2.2. Secondary Antibodies
  • 6.3. Equipment
    • 6.3.1. Slide Scanners
    • 6.3.2. Slide Staining Systems
    • 6.3.3. Tissue Microarrays
    • 6.3.4. Tissue Processing Systems
  • 6.4. Kits
  • 6.5. Reagents
    • 6.5.1. Blocking Sera & Reagents
    • 6.5.2. Chromogenic Substrates
    • 6.5.3. Diluents
    • 6.5.4. Fixation Reagents
    • 6.5.5. Histological Stains
    • 6.5.6. Organic Solvents
    • 6.5.7. Proteolytic Enzymes
    • 6.5.8. Stabilizers

7. Immunohistochemistry Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cancer
  • 7.4. Cardiovascular Diseases
  • 7.5. Diabetes Mellitus
  • 7.6. Infectious Diseases
  • 7.7. Nephrological Diseases

8. Immunohistochemistry Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. CROs
  • 8.4. Forensic Labs
  • 8.5. Hospitals & Diagnostic Laboratories
  • 8.6. Pharma & Biopharma Companies

9. Immunohistochemistry Market, by Application

  • 9.1. Introduction
  • 9.2. Diagnostics
  • 9.3. Drug Testing
  • 9.4. Forensic

10. Americas Immunohistochemistry Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Immunohistochemistry Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Immunohistochemistry Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Tempus launches advanced HER2 and FOLR1 IHC tests to enhance precision medicine and targeted cancer therapies
    • 13.3.2. Roche secures CE Mark for VENTANA HER2 (4B5) test, enhancing treatment options for HER2-low metastatic breast cancer with ENHERTU
    • 13.3.3. Cell signaling technology introduces SignalStar Multiplex IHC technology
    • 13.3.4. Danaher Corporation to acquire UK-based Abcam to enhance drug discovery and disease mapping capabilities
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies Inc.
  • 2. Becton, Dickinson & Company
  • 3. Bio SB
  • 4. Bio-Rad Laboratories Inc.
  • 5. Bio-Techne Corporation
  • 6. Biocare Medical LLC
  • 7. Biogenex Laboratories
  • 8. CANDOR Bioscience GmbH
  • 9. Cell Signaling Technology, Inc.
  • 10. Danaher Corporation
  • 11. Diagnostic BioSystems Inc.
  • 12. Eagle Biosciences, Inc.
  • 13. Elabscience Biotechnology Inc.
  • 14. F. Hoffman-La Roche AG
  • 15. Genemed Biotechnologies, Inc. by Sakura Finetek Japan Co., Ltd
  • 16. Histo-Line Laboratories
  • 17. Lunaphore Technologies SA
  • 18. Merck KGaA
  • 19. Miltenyi Biotec B.V. & Co. KG
  • 20. PerkinElmer Inc.
  • 21. Rockland Immunochemicals, Inc.
  • 22. Takara Bio, Inc
  • 23. Thermofisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. IMMUNOHISTOCHEMISTRY MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOHISTOCHEMISTRY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. IMMUNOHISTOCHEMISTRY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. IMMUNOHISTOCHEMISTRY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOHISTOCHEMISTRY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOHISTOCHEMISTRY MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 179. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 194. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 201. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 208. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 215. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 222. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 229. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 236. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 250. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 257. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 264. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 271. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 278. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 280. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 285. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 294. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 299. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 301. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 306. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 312. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 313. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 319. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 320. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 322. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 333. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 334. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 335. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 336. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 337. IMMUNOHISTOCHEMISTRY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 338. IMMUNOHISTOCHEMISTRY MARKET, FPNV POSITIONING MATRIX, 2023